Randomized phase 2 study of perampanel for sporadic amyotrophic lateral sclerosis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Randomized phase 2 study of perampanel for sporadic amyotrophic lateral sclerosis
Authors
Keywords
-
Journal
JOURNAL OF NEUROLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-06-30
DOI
10.1007/s00415-021-10670-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Perampanel Affects Up-Stream Regulatory Signaling Pathways of GluA1 Phosphorylation in Normal and Epileptic Rats
- (2019) Ji-Eun Kim et al. Frontiers in Cellular Neuroscience
- Empirical evaluation of the implementation of the EMA guideline on missing data in confirmatory clinical trials: Specification of mixed models for longitudinal data in study protocols
- (2019) Sebastian Häckl et al. PHARMACEUTICAL STATISTICS
- The Novel Direct Modulatory Effects of Perampanel, an Antagonist of AMPA Receptors, on Voltage-Gated Sodium and M-type Potassium Currents
- (2019) Lai et al. Biomolecules
- Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications
- (2018) Ruth Chia et al. LANCET NEUROLOGY
- Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study
- (2018) Ton Fang et al. LANCET NEUROLOGY
- ALS Genes in the Genomic Era and their Implications for FTD
- (2018) Hung Phuoc Nguyen et al. TRENDS IN GENETICS
- Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
- (2017) Koji Abe et al. LANCET NEUROLOGY
- Amyotrophic Lateral Sclerosis
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis
- (2016) Benoît Marin et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- The AMPA receptor antagonist perampanel robustly rescues amyotrophic lateral sclerosis (ALS) pathology in sporadic ALS model mice
- (2016) Megumi Akamatsu et al. Scientific Reports
- A revision of the El Escorial criteria - 2015
- (2015) Albert Ludolph et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial
- (2014) Merit E Cudkowicz et al. LANCET NEUROLOGY
- Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonist
- (2013) M. A. Rogawski et al. ACTA NEUROLOGICA SCANDINAVICA
- Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: A pooled analysis of three phase III studies
- (2013) Bernhard J. Steinhoff et al. EPILEPSIA
- Concentration-effect relationships with perampanel in patients with pharmacoresistant partial-onset seizures
- (2013) Barry E. Gidal et al. EPILEPSIA
- Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis
- (2013) Adriano Chiò et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published Literature
- (2013) A. Chiò et al. NEUROEPIDEMIOLOGY
- A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology
- (2012) Takenari Yamashita et al. Nature Communications
- The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults
- (2011) Kelly Posner et al. AMERICAN JOURNAL OF PSYCHIATRY
- Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons
- (2011) Takuto Hideyama et al. NEUROBIOLOGY OF DISEASE
- Induced Loss of ADAR2 Engenders Slow Death of Motor Neurons from Q/R Site-Unedited GluR2
- (2010) T. Hideyama et al. JOURNAL OF NEUROSCIENCE
- A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis
- (2009) Robert M. Pascuzzi et al. Amyotrophic Lateral Sclerosis
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More